191 related articles for article (PubMed ID: 29020844)
1. Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B infection during pregnancy: a systematic review.
Tavakolpour S; Darvishi M; Mirsafaei HS; Ghasemiadl M
Infect Dis (Lond); 2018 Feb; 50(2):95-106. PubMed ID: 29020844
[TBL] [Abstract][Full Text] [Related]
2. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.
Han GR; Cao MK; Zhao W; Jiang HX; Wang CM; Bai SF; Yue X; Wang GJ; Tang X; Fang ZX
J Hepatol; 2011 Dec; 55(6):1215-21. PubMed ID: 21703206
[TBL] [Abstract][Full Text] [Related]
3. Tenofovir rescue therapy in pregnant females with chronic hepatitis B.
Hu YH; Liu M; Yi W; Cao YJ; Cai HD
World J Gastroenterol; 2015 Feb; 21(8):2504-9. PubMed ID: 25741161
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real-life practice.
Liu J; Wang J; Yan T; Du D; Qi C; Cao F; Yao N; Yang Y; He Y; Tian Z; Ren D; Zhu L; Chen T; Zhao Y
J Viral Hepat; 2019 Oct; 26(10):1170-1177. PubMed ID: 31177596
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B.
He T; Bai Y; Cai H; Ou X; Liu M; Yi W; Jia J
Hepatol Int; 2018 Mar; 12(2):118-125. PubMed ID: 29344772
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis.
Funk AL; Lu Y; Yoshida K; Zhao T; Boucheron P; van Holten J; Chou R; Bulterys M; Shimakawa Y
Lancet Infect Dis; 2021 Jan; 21(1):70-84. PubMed ID: 32805200
[TBL] [Abstract][Full Text] [Related]
7. Safety of telbivudine treatment for chronic hepatitis B for the entire pregnancy.
Liu M; Cai H; Yi W
J Viral Hepat; 2013 Apr; 20 Suppl 1():65-70. PubMed ID: 23458527
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus.
Zhu B; Lv X; Zhao Z; Chen L; Chen X; Li C; Li S; Dai E
Medicine (Baltimore); 2021 Nov; 100(44):e27695. PubMed ID: 34871254
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
[No Abstract] [Full Text] [Related]
10. Efficacy and safety of antiviral treatment on blocking the mother-to-child transmission of hepatitis B virus: A meta-analysis.
Song J; Yang F; Wang S; Tikande S; Deng Y; Tang W; Cao G
J Viral Hepat; 2019 Mar; 26(3):397-406. PubMed ID: 30417469
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of tenofovir disoproxil fumarate or telbivudine used throughout pregnancy for the prevention of mother-to-child transmission of hepatitis B virus: A cohort study.
Li Z; Xie B; Yi N; Cai H; Yi W; Gao X
Eur J Obstet Gynecol Reprod Biol; 2022 Sep; 276():102-106. PubMed ID: 35853269
[TBL] [Abstract][Full Text] [Related]
12. [Considerations of using oral nucleos(t)ide analogues to interrupt mother-to-child transmission in HBV carrier pregnant woman with high viral load].
Ding Y; Sheng QJ; Dou XG
Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):85-87. PubMed ID: 30818909
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of nucleos(t)ide analogues to prevent hepatitis B virus mother-to-child transmission in pregnant women with high viremia: real life practice from China.
Sheng Q; Ding Y; Li B; Han C; Li Y; Zhang C; Bai H; Wang J; Zhao L; Xia T; An Z; Zhang M; Dou X
Int J Med Sci; 2018; 15(8):796-801. PubMed ID: 30008589
[No Abstract] [Full Text] [Related]
14. [Maternal-fetal outcomes of lamivudine treatment administered during late pregnancy to highly viremic mothers with HBeAg+ chronic hepatitis B].
Jiang HX; Han GR; Wang CM; Ji Y
Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):888-91. PubMed ID: 23522247
[TBL] [Abstract][Full Text] [Related]
15. Presence of Precore (C)/C Promoter Mutants in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B (CHB) Carriers During Pregnancy Does Not Correlate with Increased Risk of Liver Disease in 4 Years of Follow-Up.
Joshi SS; Gao S; Castillo E; Coffin CS
Dig Dis Sci; 2020 Jan; 65(1):204-214. PubMed ID: 31376084
[TBL] [Abstract][Full Text] [Related]
16. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load.
Pan CQ; Duan Z; Dai E; Zhang S; Han G; Wang Y; Zhang H; Zou H; Zhu B; Zhao W; Jiang H;
N Engl J Med; 2016 Jun; 374(24):2324-34. PubMed ID: 27305192
[TBL] [Abstract][Full Text] [Related]
17. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice.
Zhang H; Pan CQ; Pang Q; Tian R; Yan M; Liu X
Hepatology; 2014 Aug; 60(2):468-76. PubMed ID: 25187919
[TBL] [Abstract][Full Text] [Related]
18. Mixed treatment comparison meta-analysis evaluating the relative efficacy of nucleos(t)ides for treatment of nucleos(t)ide-naive patients with chronic hepatitis B.
Dakin H; Fidler C; Harper C
Value Health; 2010 Dec; 13(8):934-45. PubMed ID: 20825624
[TBL] [Abstract][Full Text] [Related]
19. Is the use of Tenofovir Dipivoxil fumarate effective and safe in preventing vertical transmission in pregnant women with chronic HBV with high viral load?
Aladag H; Aladag M
Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2091-2098. PubMed ID: 36930508
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection.
Celen MK; Mert D; Ay M; Dal T; Kaya S; Yildirim N; Gulsun S; Barcin T; Kalkanli S; Dal MS; Ayaz C
World J Gastroenterol; 2013 Dec; 19(48):9377-82. PubMed ID: 24409065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
